[18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 599-604

  Liu, Feng Yuan ^a   Chang, Joseph T ^a   Wang, Hung Ming ^a   Liao, Chun Ta ^a   Kang, Chung Jan ^a   Ng, Shu Kung ^a   Chan, Sheng Chieh ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; BONE TUMOR; CARCINOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SCINTISCANNING; STATISTICAL MODEL; SURVIVAL;

ADULT; AGED; BONE NEOPLASMS; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 33644844928     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.8760     Document Type: Article

References (35)

1. Busson P, Keryer C, Ooka T, et al: EBV-associated nasopharyngeal carcinomas: From epidemiology to virus-targeting strategies. Trends Microbiol 12:356-360, 2004
2. Shanmugaratnam K, Sobin LH: The World Health Organization histological classification of tumours of the upper respiratory tract and ear. Cancer 71:2689-2697, 1993
3. Chan ATC, Teo PML, Huang DP: Pathogenesis and treatment of nasopharyngeal carcinoma. Semin Oncol 31:794-801, 2004
4. Chiesa F, De Paoli F: Distant metastases from nasopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 63:214-216, 2001
5. Ferlito A, Shaha AR, Silver CE, et al: Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 63:202-207, 2001
6. Algra PR, Bloem JL, Tissing H, et al: Detection of vertebral metastases: Comparison between MR imaging and bone scintigraphy. Radiographics 11:219-232, 1991
7. Geara FB, Sanguineti G, Tucker SL, et al: Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival. Radiother Oncol 43:53-61, 1997
8. Caglar M, Ceylan E, Ozyar E: Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: Should bone scans be used for follow-up? Nucl Med Commun 24:1231-1236, 2003
9. Ng S-H, Chang JT-C, Chan S-C, et al: Nodal metastases of nasopharyngeal carcinoma: Patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging 31:1073-1080, 2004
10. 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med 46:405-410, 2005
11. Hamaoka T, Madewell JE, Podoloff DA, et al: Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942-2953, 2004
12. Fogelman I, Cook G, Israel O, et al: Positron emission tomography and bone metastases. Semin Nucl Med 35:135-142, 2005
13. Cheran SK, Herndon JE II, Patz EF Jr: Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44:317-325, 2004
14. Peterson JJ, Kransdorf MJ, O'Connor MI: Diagnosis of occult bone metastases: Positron emission tomography. Clin Orthop 415S:S120-S128, 2003 (suppl)
15. 18F PET. J Nucl Med 40:1623-1629, 1999
16. Roodman GD: Mechanisms of bone metastasis. N Engl J Med 350:1655-1664, 2004
17. 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375-3379, 1998
18. Micheau C, Boussen H, Klijanienko J, et al: Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type. Cancer 60:2459-2464, 1987
19. Sham JS, Cheung YK, Chan FL, et al: Nasopharyngeal carcinoma: Pattern of skeletal metastases. Br J Radiol 63:202-205, 1990
20. Pantel K, Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4:448-456, 2004
21. Hsu MM, Tu SM: Nasopharyngeal carcinoma in Taiwan: Clinical manifestations and results of therapy. Cancer 52:362-368, 1983
22. Teo PM, Kwan WH, Lee WY, et al: Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77:2423-2431, 1996
23. Hui EP, Leung SF, Au JSK, et al: Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group. Cancer 101:300-306, 2004
24. Kwan WH, Teo PML, Chow LTC, et al: Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: An indication for more aggressive treatment. Clin Oncol (R Coll Radiol) 8:55-58, 1996
25. Sugawara Y, Fisher SJ, Zasadny KR, et al: Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16:173-180, 1998
26. Vande Berg BC, Lecouvet FE, Galant C, et al: Normal variants and frequent marrow alterations that simulate bone marrow lesions at MR imaging. Radiol Clin North Am 43:761-770, 2005
27. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572, 2002
28. Braun S, Naume B: Circulating and disseminated tumor cells. J Clin Oncol 23:1623-1626, 2005
29. Faye RS, Aamdal S, Hoifodt HK, et al: Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients. Clin Cancer Res 10:4134-4139, 2004
30. Jiao X, Krasna MJ: Clinical significance of micrometastasis in lung and esophageal cancer: A new paradigm in thoracic oncology. Ann Thorac Surg 74:278-284, 2002
31. Orr FW, Lee J, Duivenvoorden WC, et al: Pathophysiologic interactions in skeletal metastasis. Cancer 88:2912-2918, 2000
32. Lauenstein TC, Goehde SC, Herborn CU, et al: Whole-body MR imaging: Evaluation of patients for metastases. Radiology 233:139-148, 2004
33. Daldrup-Link HE, Franzius C, Link TM, et al: Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177:229-236, 2001
34. 18F-fluoride PET/CT. J Nucl Med 45:272-278, 2004
35. Schirrmeister H, Guhlmann A, Kotzerke J, et al: Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17:2381-2389, 1999